Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Timothy Garvey

Showing results (131-140 of 265) with videos related to

Pageof 27
Sort By:
Diabetes, Obesity & Metabolism|May 5, 2025
Tirzepatide 10 and 15 mg versus semaglutide 2.4 mg in people with obesity or overweight with type 2 diabetes: An indirect treatment comparisonEmily R Hankosky, Xuanyao He, Raleigh Malik, et al.
Human Biology|August 29, 2003
Three novel mtDNA restriction site polymorphisms allow exploration of population affinities of African AmericansDavid C McLean, Ida Spruill, Sahr Gevao, et al.
Metabolism: Clinical and Experimental|February 17, 2018
Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetesW Timothy Garvey, Luc Van Gaal, Lawrence A Leiter, et al.
Diabetes Care|September 25, 2014
Weight-loss therapy in type 2 diabetes: effects of phentermine and topiramate extended releaseW Timothy Garvey, Donna H Ryan, Nancy J V Bohannon, et al.
Obesity (Silver Spring, Md.)|April 26, 2017
Coadministration of lorcaserin and phentermine for weight management: A 12-week, randomized, pilot safety studySteven R Smith, W Timothy Garvey, Frank L Greenway, et al.
Obesity (Silver Spring, Md.)|January 5, 2025
The impact of a low-carbohydrate (vs. low-fat) diet on fat mass loss in African American women is modulated by insulin sensitivityCatia Martins, David R Bryan, S Katherine Sweatt, et al.
Diabetes, Obesity & Metabolism|September 13, 2023
Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT-1 trialEmily R Hankosky, Hui Wang, Lisa M Neff, et al.
Diabetes Care|October 10, 2013
Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended releaseW Timothy Garvey, Donna H Ryan, Robert Henry, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 4, 2023
American Association of Clinical Endocrinology Consensus Statement: Addressing Stigma and Bias in the Diagnosis and Management of Patients with Obesity/Adiposity-Based Chronic Disease and Assessing Bias and Stigmatization as Determinants of Disease SeverityKarl Nadolsky, Brandi Addison, Monica Agarwal, et al.
Population Health Management|March 30, 2021
Building Successful Models in Primary Care to Improve the Management of Adult Patients with ObesityDanielle Casanova, Robert F Kushner, Elizabeth L Ciemins, et al.
Pageof 27

Showing results (131-140 of 265) with videos related to

Sort By:
Pageof 27
Diabetes, Obesity & Metabolism|May 5, 2025
Tirzepatide 10 and 15 mg versus semaglutide 2.4 mg in people with obesity or overweight with type 2 diabetes: An indirect treatment comparisonEmily R Hankosky, Xuanyao He, Raleigh Malik, et al.
Human Biology|August 29, 2003
Three novel mtDNA restriction site polymorphisms allow exploration of population affinities of African AmericansDavid C McLean, Ida Spruill, Sahr Gevao, et al.
Metabolism: Clinical and Experimental|February 17, 2018
Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetesW Timothy Garvey, Luc Van Gaal, Lawrence A Leiter, et al.
Diabetes Care|September 25, 2014
Weight-loss therapy in type 2 diabetes: effects of phentermine and topiramate extended releaseW Timothy Garvey, Donna H Ryan, Nancy J V Bohannon, et al.
Obesity (Silver Spring, Md.)|April 26, 2017
Coadministration of lorcaserin and phentermine for weight management: A 12-week, randomized, pilot safety studySteven R Smith, W Timothy Garvey, Frank L Greenway, et al.
Obesity (Silver Spring, Md.)|January 5, 2025
The impact of a low-carbohydrate (vs. low-fat) diet on fat mass loss in African American women is modulated by insulin sensitivityCatia Martins, David R Bryan, S Katherine Sweatt, et al.
Diabetes, Obesity & Metabolism|September 13, 2023
Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT-1 trialEmily R Hankosky, Hui Wang, Lisa M Neff, et al.
Diabetes Care|October 10, 2013
Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended releaseW Timothy Garvey, Donna H Ryan, Robert Henry, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 4, 2023
American Association of Clinical Endocrinology Consensus Statement: Addressing Stigma and Bias in the Diagnosis and Management of Patients with Obesity/Adiposity-Based Chronic Disease and Assessing Bias and Stigmatization as Determinants of Disease SeverityKarl Nadolsky, Brandi Addison, Monica Agarwal, et al.
Population Health Management|March 30, 2021
Building Successful Models in Primary Care to Improve the Management of Adult Patients with ObesityDanielle Casanova, Robert F Kushner, Elizabeth L Ciemins, et al.
Pageof 27